Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.54 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.54 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.54 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.54 |
| ▸ | WDR5 | P61964 | 15/20 | 0.48 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.45 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.45 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29315350 | 1.00 | LMNA (0.55) | LMNAGAAAPOBEC3ACTDSP1APOBEC3G | |
| SCHEMBL13907367 | 0.83 | LMNA (0.53) | LMNAGAAAPOBEC3ACTDSP1APOBEC3G | |
| SCHEMBL560405 | 0.82 | LMNA (0.71) | LMNAGAAAPOBEC3ACTDSP1APOBEC3G | |
| SCHEMBL17186490 | 0.78 | PTGIR (0.61) | LMNAGAAAPOBEC3ACTDSP1APOBEC3G | |
| SCHEMBL8146510 | 0.77 | LMNA (0.58) | LMNAGAAAPOBEC3ACTDSP1APOBEC3G | |
| Hydrochloric Acid SCHEMBL18605409 | 0.77 | PTGIR (0.59) | LMNAGAAAPOBEC3ACTDSP1APOBEC3G | |
| SCHEMBL13063071 | 0.77 | LMNA (0.64) | LMNAGAAAPOBEC3ACTDSP1APOBEC3G | |
| Iodide SCHEMBL3168283 | 0.76 | LMNA (0.60) | LMNAGAAAPOBEC3ACTDSP1APOBEC3G | |
| Hydrochloric Acid SCHEMBL4687702 | 0.75 | ADRA2A (0.64) | ADRA2AADRA2BADRA2C | |
| SCHEMBL561403 | 0.74 | LMNA (0.62) | LMNAGAAAPOBEC3ACTDSP1APOBEC3G |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4684834-A1 | CRYSTALLINE FORMS OF ONCOLOGICALLY ACTIVE IMIPRIDONES AND PROCESS FOR THEIR PREPARATION | BRIU GmbH (DE) | 2026-01-28 | — | — | EP | disclosed |